Disease activity and transition outcomes in a childhood-onset systemic lupus erythematosus cohort

Mary Beth F. Son(Boston Children's Hospital), KH Costenbader(Brigham and Women's Hospital), Hongshu Guan(Brigham and Women's Hospital), Y. Sergeyenko(University of Miami)
Lupus
March 24, 2016
10.1177/0961203316640913
Cited by 71

Related Papers

Multisystem Inflammatory Syndrome in U.S. Children and Adolescents
|New England Journal of Medicine|2020|2.7k
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
|JAMA|2021|852
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1
|Arthritis & Rheumatology|2020|537
Anakinra as first‐line disease‐modifying therapy in systemic juvenile idiopathic arthritis: Report of forty‐six patients from an international multicenter series
|Arthritis & Rheumatism|2010|465
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2
|Arthritis & Rheumatology|2020|415